Yoshioka A - Search Results

1

Efficacy of auxiliary partial orthotopic liver transplantation for cure of hemophilia in a canine hemophilia A model.

Ko S, Tanaka I, Kanokogi H, Kanehiro H, Okayama J, Ori J, Shima M, Yoshioka A, Giles A, Nakajima Y. Ko S, et al. Among authors: yoshioka a. Transplant Proc. 2005 Mar;37(2):1131-3. doi: 10.1016/j.transproceed.2005.01.003. Transplant Proc. 2005. PMID: 15848646

2

Preclinical experiment of auxiliary partial orthotopic liver transplantation as a curative treatment for hemophilia.

Ko S, Tanaka I, Kanehiro H, Kanokogi H, Ori J, Shima M, Yoshioka A, Giles A, Nakajima Y. Ko S, et al. Among authors: yoshioka a. Liver Transpl. 2005 May;11(5):579-84. doi: 10.1002/lt.20390. Liver Transpl. 2005. PMID: 15838867 Free article.

3

Therapeutic effects of hepatocyte transplantation on hemophilia B.

Tatsumi K, Ohashi K, Shima M, Nakajima Y, Okano T, Yoshioka A. Tatsumi K, et al. Among authors: yoshioka a. Transplantation. 2008 Jul 15;86(1):167-70. doi: 10.1097/TP.0b013e31817b9160. Transplantation. 2008. PMID: 18622295

4

Inversions of the factor VIII gene in Japanese patients with severe hemophilia A.

Fukuda K, Naka H, Morichika S, Shibata M, Tanaka I, Shima M, Yoshioka A. Fukuda K, et al. Among authors: yoshioka a. Int J Hematol. 2004 Apr;79(3):303-6. doi: 10.1532/ijh97.03138. Int J Hematol. 2004. PMID: 15168603

5

Association of anti-idiotypic antibodies with immune tolerance induction for the treatment of hemophilia A with inhibitors.

Sakurai Y, Shima M, Tanaka I, Fukuda K, Yoshida K, Yoshioka A. Sakurai Y, et al. Among authors: yoshioka a. Haematologica. 2004 Jun;89(6):696-703. Haematologica. 2004. PMID: 15194537

6

Successful in vivo propagation of factor IX-producing hepatocytes in mice: potential for cell-based therapy in haemophilia B.

Tatsumi K, Ohashi K, Kataoka M, Tateno C, Shibata M, Naka H, Shima M, Hisanaga M, Kanehiro H, Okano T, Yoshizato K, Nakajima Y, Yoshioka A. Tatsumi K, et al. Among authors: yoshioka a. Thromb Haemost. 2008 May;99(5):883-91. doi: 10.1160/TH07-09-0559. Thromb Haemost. 2008. PMID: 18449417

7

The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C).

Shima M, Matsumoto T, Fukuda K, Kubota Y, Tanaka I, Nishiya K, Giles AR, Yoshioka A. Shima M, et al. Among authors: yoshioka a. Thromb Haemost. 2002 Mar;87(3):436-41. Thromb Haemost. 2002. PMID: 11916076

8

Clinical evaluation of recombinant human factor VIII (BAY w 6240) in the treatment of hemophilia A.

Fukui H, Yoshioka A, Shima M, Tanaka I, Koshihara K, Fukutake K, Fujimaki M. Fukui H, et al. Among authors: yoshioka a. Int J Hematol. 1991 Oct;54(5):419-27. Int J Hematol. 1991. PMID: 1756252 Clinical Trial.

9

Measurement of anti-factor VIII IgG, IgG4 and IgM alloantibodies in previously untreated hemophilia A patients treated with recombinant factor VIII. Kogenate Japanese Clinical Study Group.

Shima M, Sawamoto Y, Nakai H, Kamisue S, Murakami T, Morichika S, Tanaka I, Hayashi K, Yoshioka A. Shima M, et al. Among authors: yoshioka a. Int J Hematol. 1995 Jul;62(1):35-43. doi: 10.1016/0925-5710(95)00378-6. Int J Hematol. 1995. PMID: 7670006 Clinical Trial.

10

Thrombelastgram as a hemostatic monitor during recombinant factor VIIa treatment in hemophilia A patients with inhibitor to factor VIII.

Yoshioka A, Nishio K, Shima M. Yoshioka A, et al. Haemostasis. 1996;26 Suppl 1:139-42. doi: 10.1159/000217256. Haemostasis. 1996. PMID: 8904189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

636 results

Search Page

Filters